论文部分内容阅读
目的:探究分析幽门螺旋杆菌阳性胃溃疡患者采取雷贝拉唑联合磷酸铝凝胶治疗临床效果。方法:参与本实验幽门螺旋杆菌阳性胃溃疡患者共70例,按照其入院单双号分成对照组和研究组,每组患者均35例。对照组患者应用雷贝拉唑治疗,研究组在其基础上加行磷酸铝凝胶治疗。结果:相比于对照组,研究组患者幽门螺旋杆菌根除率及临床治疗总有效率指标均更高,数据差异显著(P<0.05),临床效果明显。结论:幽门螺旋杆菌阳性胃溃疡患者在临床治疗中应用雷贝拉唑联合磷酸铝凝胶方案治疗,能够在最短时间内控制患者病情发展,有效根除幽门螺旋杆菌,达到预期临床效果。
Objective: To investigate the clinical efficacy of rabeprazole combined with aluminum phosphate gel in patients with Helicobacter pylori-positive gastric ulcer. Methods: A total of 70 patients with Helicobacter pylori-positive gastric ulcer participated in this study. They were divided into control group and study group according to their admission single and double numbers, with 35 patients in each group. Patients in the control group were treated with rabeprazole, and the study group was treated with aluminum phosphate gel on the basis of the group. Results: Compared with the control group, the eradication rate of Helicobacter pylori and the total effective rate of clinical treatment in the study group were significantly higher (P <0.05), and the clinical effect was obvious. Conclusion: Helicobacter pylori-positive gastric ulcer patients treated with rabeprazole combined with aluminum phosphate gel in clinical treatment can control the progression of patients in the shortest time and effectively eliminate Helicobacter pylori to achieve the expected clinical effect.